Pediatric Gastroenterology Hepatology & Nutrition · 2018 · 19 citations · 22 references
MedicineChild HealthPediatricsAdolescent HealthPediatric EpidemiologyPediatric GastroenterologyColonic DiseasesInflammatory Bowel DiseasePediatric Gastrointestinal DisordersPediatric Intestinal DisordersCohort Study InvestigationInflammatory Bowel Disease Activity AssessmentMorbidity IndicatorsPediatric Ulcerative ColitisRetrospective Case StudyTumor Necrosis Factor TherapyVery Early Onset Inflammatory Bowel Disease
Purpose: Monogenic inflammatory bowel disease (IBD) patients do not respond to conventional therapy and are associated with a higher morbidity. We summarized the clinical characteristics of monogenic IBD patients and compared their clinical outcomes to that of non-monogenic IBD patients. Methods: We performed a retrospective cohort study of all children 18 years old who were diagnosed with IBD between 2005 and 2016. A total of 230 children were enrolled. Monogenic IBD was defined as a presentation age less than 6 years old with confirmation of a genetic disorder. We subdivided the groups into monogenic IBD (n=18), non-monogenic very early-onset IBD (defined as patients with a presentation age 6 years old without a confirmed genetic disorder, n=12), non-monogenic IBD (defined as all patients under 18 years old excluding monogenic IBD, n=212), and severe IBD (defined as patients treated with an anti-tumor necrosis factor excluding monogenic IBD, n=92). We compared demographic data, initial pediatric Crohn disease activity index/pediatric ulcerative colitis activity index (PCDAI/PUCAI) score, frequency of hospitalizations, surgical experiences, and height and weight under 3rd percentile among the patients enrolled. Results: The initial PCDAI/PUCAI score (p0.05), incidence of surgery per year (p0.05), and hospitalization per year (p0.05) were higher in the monogenic IBD group than in the other IBD groups. Additionally, the proportion of children whose weight and height were less than the 3rd percentile (p0.05 and p0.05, respectively) was also higher in the monogenic IBD group. Conclusion: Monogenic IBD showed more severe clinical manifestations than the other groups.
22
Infant colitis—it's in the genes
Erik‐Oliver Glocker, Natalie Frede, Mario Perro et al. · The Lancet · 2010 · 266 citations